Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

BioX­cel tout­ed da­ta Thurs­day morn­ing claim­ing that Igal­mi, its drug for ag­i­ta­tion episodes, suc­ceed­ed in a piv­otal tri­al with Alzheimer’s pa­tients, re­duc­ing a com­pos­ite of

The FDA is rais­ing con­cerns about in­creased rates of hy­po­glycemia fol­low­ing treat­ment with No­vo Nordisk’s ex­per­i­men­tal once-week­ly basal in­sulin ahead of an ad­vi­so­ry com­mit­tee meet­ing